The week of November 11, 2013, saw release of the long-awaited update to what had become a stale approach to cholesterol management in the long-term war against cardiovascular disease. Is the document a radical departure from what had gone before? The answer is a resounding “yes.”
A 15-year-old boy presents for evaluation after a syncopal episode while playing football. He denies any current headache, chest pain, or shortness of breath. He admits to feeling heart palpitations before losing consciousness.